anti arrhythmic drugs Flashcards
What are class III anti-arrhythmic agents ?
They are potassium channel blockers that inhibit potassium outward current or refflux.
Class I agents work by blocking ____________
Cardiac voltage-operated sodium channels
list four class 2 anti arrhythmic agents?
propranolol (non-selective)
atenolol
metoprolol
bisoprolol (ß1-adrenoceptor (cardio)selective)
The major anti-arrhythmic action of class 1 therapeutic contributions are to interrupt ________
re-entry circuits and reduce automaticity
Class 1 chief related site of action is phase 0 of non-nodal Myocardial cells, what do they do to stop arrhythmias?
they act on Myocardial cells; and in particular, rapid sodium inward current during (phase 0) depolarisation.
with class 1 agents, Sodium entry is inhibited and phase 0 depressed. what is achieved by doing this?
Reduced excitability and slowed impulse conduction (decreased conduction velocity)
Class I agents are further subdivided into class _________
IA, IB and IC
class IA agents exhibit the additional property of _____________ (which leads to an extended action potential arising from a protracted phase 2/delayed phase 3
Potassium channel blockade
List three three class 1 drugs
Flecainide (Class 1C agent)
Lidocaine (Class 1B agent)
Quinidine (Class 1A agent)
List the mechanism of Lidocaine
Mild sodium channel blockade
Associates and dissociates rapidly with sodium channel, prefers open and inactivated states for binding, targets ischaemic tissue with little effect on normal myocardium
List the mechanism of Flecainide
Marked sodium channel blockade
Associates and dissociates slowly with sodium channel, affects normal + damaged myocardium non-selectively
List the mechanism of Quinidine
Moderate sodium channel blockade
Associates and dissociates at intermediate rate with sodium channel
Name three class III anti-arrhythmic agents
amiodarone,
dronedarone
vernakalant
What are the effects of class III anti-arrhythmic agents ?
Delays phase 3 repolarisation (inhibit potassium loss) and extends phase 2 in non-nodal cells.
Increases action potential duration and refractory period
Reduce possibility of re-entry circuits
What are class IV anti-arrhythmic drugs?
calcium entry blockers of the non-dihydropyridine class, which exhibit pronounced activity at voltage-operated, cardiac L-type calcium channels